key: cord-1026986-04w2w5c2 authors: Kaku, Norihito; Ota, Kenji; Sasaki, Daisuke; Akamatsu, Norihiko; Uno, Naoki; Sakamoto, Kei; Kosai, Kosuke; Hasegawa, Hiroo; Izumikawa, Koichi; Mukae, Hiroshi; Yanagihara, Katsunori title: Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? date: 2021-03-27 journal: Microbes Infect DOI: 10.1016/j.micinf.2021.104812 sha: 9dec722271e2028705fd3c50214832e1990ddf39 doc_id: 1026986 cord_uid: 04w2w5c2 This retrospective study evaluated stored nasopharyngeal swab samples from Japanese patients with influenza-like illness during the 2019/2020 season. We aimed to determine whether COVID-19 had spread in the community before the first confirmed case. The period of influenza season during 2019/2020 in Nagasaki was shorter than in previous influenza seasons. When the first COVID-19 case was reported in Nagasaki prefecture, the number of influenza cases were very low. No positive results for SARS-CoV-2 were detected in 182 samples that were obtained from adult outpatients. Our results revealed no large-scale spread of COVID-19 in the community before the first confirmed case. The first outbreak of coronavirus disease-19 in Wuhan, China was reported on December 31, 2019. However, symptom onset in the first COVID-19 case from the first outbreak occurred on December 8, 2019 [1] , and there is a possibility that COVID-19 had spread worldwide before the first reported outbreak. In France, the COVID-19 epidemic began during late January 2020, although Deslandes et al. have reported a patient with a stored respiratory sample from late December 2019 that was positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [2] . In Japan, the first confirmed COVID-19 case was reported on January 14, 2020, although the patient had returned from China on January 6, 2020. Thus, testing for SRAS-CoV-2 has been conducted for individuals who return from COVID-19 endemic areas. The first confirmed COVID-19 case in Nagasaki prefecture involved a man who had close contact with a COVID-19 case in another area, and SARS-CoV-2 was detected on March 14, 2020. However, there is a possibility that COVID-19 had spread in the community before that date, as Nagasaki prefecture is geographically close to China and had accepted many Chinese tourists, including one cruise ships. Furthermore, the number of patients with influenza was lower than normal during the 2019/2020 season. As the clinical symptoms of COVID-19 and influenza are similar, we conducted a retrospective study of stored nasopharyngeal swab samples from patients in Nagasaki with influenza-like illness during the 2019/2020 season. These specimens had been J o u r n a l P r e -p r o o f collected as part of a previous study regarding novel influenza tests [3] , and were used in the present study to evaluate whether COVID-19 had spread in the community before the first confirmed case. This retrospective study was approved by the ethics committee of Nagasaki University Hospital (20061508) and was registered in the UMIN Clinical Trials Registry (UMIN000040278). The patients had previously provided informed consent for sample collection and data publication as part of a previous study regarding novel influenza tests [3] . A number of weekly influenza cases per sentinel hospital or clinic in Nagasaki prefecture between the 2015/2016 and 2019/2020 seasons were obtained from a weekly influenza report provided by the National Institute of Infectious Diseases [4] . Influenza season was defined as when a number of weekly influenza cases per sentinel hospital or clinic was 1.0 or more. Data regarding newly confirmed cases in Nagasaki prefecture were obtained from a prompt report provided by the Nagasaki Prefectural Government [5] . Patient characteristics were collected from the previous study's database [3] . The nasopharyngeal swab samples had been J o u r n a l P r e -p r o o f 6 collected between November 15, 2019 and March 14, 2020 from 182 adult outpatients with influenza-like illness who had one or more symptoms, such as fever (≥38°C or an increase of ≥1°C from normal body temperature), nasal discharge, nasal congestion, sore throat, cough, headache, chills, fatigue, joint pain, or muscle pain at 4 hospitals and clinics in Nagasaki prefecture [3] . Patients treated with anti-influenza agents 1 month prior to the clinic or hospital visit were excluded in the previous study [3] . Two sets of nasopharyngeal swab samples were collected from each patient. One set was immediately subjected to automated immunochromatographic antigen tests for detecting influenza virus (BD Veritor System Flu; Becton, Dickinson and Company, Tokyo, Japan) and the other set was stored in 3 mL of universal transport medium (Copan Italia spa, Brescia, Italy) at -80°C until further analysis [3] . Nucleic acid amplification assays were performed using a protocol that was published by the National Institute of Infectious Diseases [6] . Total nucleic acids were extracted from the samples using the MagMAX Viral/Pathogen Nucleic Acid Isolation kit (ThermoFisher The duration of the influenza season in Nagasaki prefecture during 2019/2020 was shorter and the peak was lower than in previous seasons. Sakamoto et al. have also reported that the seasonal influenza activity was lower during 2020 than during previous years in Japan [7] . Furthermore, they reported that the number of influenza cases decreased from week 5, which is similar to our results. Thus, similar trends regarding influenza activity were observed in Nagasaki prefecture and Japan as a whole during 2020. However, the first influenza case was confirmed in Nagasaki prefecture 9 weeks later than the first case in Japan (week 12 in Nagasaki and week 3 in Japan) [7] . In addition, Nagasaki prefecture is one of the Japanese regions that is geographically closest to China, with many Chinese cruise ships docking at the Nagasaki port until week 6 of 2020 [8]. These facts suggest that COVID-19 spread in the Nagasaki community might have influenced the low influenza activity, although we did not identify any positive results for SARS-CoV-2 in the nasopharyngeal swabs from 182 adult outpatients. Similarly, no positive results for SARS-CoV-2 were detected in studies of pre-pandemic nasopharyngeal swab samples from patients in Italy [9] and Switzerland [10] . Furthermore, nasopharyngeal swabs are the standard specimen for detecting SARS-CoV-2 [11] , and the swabs for the present study had been obtained from healthcare workers and carefully stored [3] . Therefore, this study did not reveal evidence of COVID-19 spread in the Nagasaki community before the first confirmed case. The present study is unable to clarify the reason for relatively low influenza activity during Week of year WHO | Novel Coronavirus -China n.d SARS-CoV-2 was already spreading in France in late Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness Infectious Diseases Weekly Reports n New confirmed cases in Nagasaki Prefecture n National Institution of the Infectious Disease. Manual for the Detection of Pathogen 2019-nCoV Ver.2 Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance No evidence of SARS-CoV-2 circulation before identification of the first Swiss SARS-CoV-2 case Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease The authors thank the physicians, nurses, and clinical technologists at the Narita Naika Clinic, Matsumoto Naika, Shinzato Medicare Group Shinzato Clinic, and Menoto Hospital for their important contribution to the sample and data collection. The authors also thank the clinical technologists at the Department of Laboratory Medicine, Nagasaki University Hospital for their contribution to SARS-CoV-2 testing in this study. The authors have no conflict of interest directly relevant to the content of this article.